FDA Approves Tebentafusp-tebn for the Treatment of Unresectable or Metastatic Uveal Melanoma – The ASCO Post

By The ASCO Post Staff Posted: 1/26/2022 2:23:00 PM Last Updated: 1/26/2022 3:28:55 PM On January 26, the U.S. Food and Drug Administration (FDA) granted approval to tebentafusp-tebn (Kimmtrak) for the treatment of adult patients with HLA-A*02:01–positive, unresectable or…

Read the full article here

Related Articles